Rhumbline Advisers Sells 4,225 Shares of Surgery Partners, Inc. $SGRY

Rhumbline Advisers cut its holdings in Surgery Partners, Inc. (NASDAQ:SGRY) by 3.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 117,627 shares of the company’s stock after selling 4,225 shares during the period. Rhumbline Advisers owned 0.09% of Surgery Partners worth $2,794,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. AlphaQuest LLC increased its stake in Surgery Partners by 112.0% during the first quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock valued at $25,000 after acquiring an additional 559 shares during the period. PNC Financial Services Group Inc. increased its stake in Surgery Partners by 86.4% during the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock valued at $28,000 after acquiring an additional 542 shares during the period. Summit Securities Group LLC bought a new position in Surgery Partners during the first quarter valued at about $31,000. DekaBank Deutsche Girozentrale bought a new position in Surgery Partners during the first quarter valued at about $65,000. Finally, State of Wyoming increased its stake in Surgery Partners by 94.4% during the fourth quarter. State of Wyoming now owns 4,002 shares of the company’s stock valued at $85,000 after acquiring an additional 1,943 shares during the period.

Analyst Ratings Changes

SGRY has been the topic of several research reports. Bank of America initiated coverage on Surgery Partners in a research note on Monday, July 28th. They set a “buy” rating and a $28.00 price target on the stock. Barclays lowered their price objective on Surgery Partners from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 27th. Six investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $33.00.

Surgery Partners Price Performance

SGRY stock opened at $21.56 on Wednesday. The stock has a 50-day moving average price of $22.43 and a two-hundred day moving average price of $22.52. The stock has a market cap of $2.76 billion, a PE ratio of -15.08 and a beta of 1.76. The company has a current ratio of 1.93, a quick ratio of 1.78 and a debt-to-equity ratio of 1.10. Surgery Partners, Inc. has a 1 year low of $18.87 and a 1 year high of $33.90.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $826.20 million during the quarter, compared to analysts’ expectations of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The company’s revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.21 EPS. Equities analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Insider Transactions at Surgery Partners

In other news, Director Teresa Deluca sold 20,018 shares of the firm’s stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total value of $455,209.32. Following the completion of the transaction, the director owned 45,173 shares in the company, valued at $1,027,234.02. This trade represents a 30.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Harrison R. Bane sold 9,339 shares of the firm’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $22.48, for a total value of $209,940.72. Following the completion of the transaction, the insider owned 117,181 shares of the company’s stock, valued at $2,634,228.88. The trade was a 7.38% decrease in their position. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by corporate insiders.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.